187 Episodo

  1. Giuseppe Citerio on frailty and TBI

    Publicado: 19/1/2022
  2. Alberto Costa on memantine in adolescents and young adults with Down syndrome

    Publicado: 20/12/2021
  3. Olivier Rascol on amantadine for patients with movement disorders

    Publicado: 17/11/2021
  4. Antonio Uccelli on stems cells for MS

    Publicado: 20/10/2021
  5. Priya Palta on blood pressure control and cognitive decline

    Publicado: 15/9/2021
  6. Adam Boxer on tau biomarkers

    Publicado: 18/8/2021
  7. Irene Cortese on the difficulties of designing clinical trials

    Publicado: 21/7/2021
  8. Doug Turnbull on mitochondrial diseases in adults

    Publicado: 16/6/2021
  9. Geert Jan Biessels on predicting post-stroke cognitive impairment

    Publicado: 19/5/2021
  10. Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS

    Publicado: 21/4/2021
  11. Anne MacGregor on menstrual migraine

    Publicado: 17/3/2021
  12. Peter Rothwell on asymptomatic carotid stenosis and stroke

    Publicado: 17/2/2021
  13. Spinal cord injury and degenerative cervical myelopathy

    Publicado: 20/1/2021
  14. Genetic risk factors for sCJD

    Publicado: 22/12/2020
  15. Prednisone in short-term prevention of cluster headache

    Publicado: 24/11/2020
  16. PET imaging of inflammation in neurological and psychiatric disorders

    Publicado: 21/10/2020
  17. Neurological associations of COVID-19

    Publicado: 4/9/2020
  18. Advances in understanding of Rett syndrome

    Publicado: 31/7/2020
  19. Management of Parkinson's disease

    Publicado: 17/6/2020
  20. Optimal time to treat Huntington's Disease

    Publicado: 26/5/2020

3 / 10

Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.

Visit the podcast's native language site